Retrovirus-mediated Expression of Apolipoprotein A-I in the Macrophage Protects against Atherosclerosis in Vivo

Hiroyuki Ishiguro, Hiroaki Yoshida, Amy S. Major, Tianli Zhu, Vladimir R. Babaev, MacRae F. Linton, Sergio Fazio

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

We have previously reported that the lack of apolipoprotein (apo) E expression by macrophages promotes foam cell formation in vivo. Because transgenic mice overexpressing human apoA-I from the liver (h-apoA-I TgN) are protected from the atherogenesis induced by apoE deficiency, we hypothesized that the presence of apoA-I in the vessel wall could reduce the negative effect of apoE deficiency on lesion growth. To address this issue, we used both retroviral transduction and transgenic approaches to produce in vivo systems where apoA-I is expressed from macrophages. In the retroviral transduction study, apoA-I-deficient (apoA-I-/-) mice reconstituted with apoE-deficient (apoE-/-) bone marrow cells that were infected with a retroviral vector expressing human apoA-I (MFG-HAI) had 95% lower atherosclerotic lesion area than that of recipients of apoE-/- bone marrow cells infected with the parental virus (MFG). To determine whether the protective effect of locally produced apoA-I was due to the lack of systemic apoA-I, we conducted a different experiment using h-apoA-I TgN mice as recipients of apoE-/- bone marrow with or without human apoA-I (driven by a macrophage-specific transgene defined as mφ-AI). Aortic lesion area in apoE-/-/mφ-AI → h-apoA-I TgN mice was decreased by 85% compared with apoE-/- → h-apoA-I TgN mice. These data demonstrate that expression of apoA-I from macrophages protects against atherogenesis without affecting plasma apoA-I and high density lipoprotein cholesterol levels.

Original languageEnglish (US)
Pages (from-to)36742-36748
Number of pages7
JournalJournal of Biological Chemistry
Volume276
Issue number39
DOIs
StatePublished - Sep 28 2001
Externally publishedYes

Fingerprint

Macrophages
Apolipoprotein A-I
Retroviridae
Atherosclerosis
Apolipoproteins E
Bone
Bone Marrow Cells
Cells
Foam Cells
Transgenes
Viruses
Liver
HDL Cholesterol
Transgenic Mice
Foams

ASJC Scopus subject areas

  • Biochemistry

Cite this

Retrovirus-mediated Expression of Apolipoprotein A-I in the Macrophage Protects against Atherosclerosis in Vivo. / Ishiguro, Hiroyuki; Yoshida, Hiroaki; Major, Amy S.; Zhu, Tianli; Babaev, Vladimir R.; Linton, MacRae F.; Fazio, Sergio.

In: Journal of Biological Chemistry, Vol. 276, No. 39, 28.09.2001, p. 36742-36748.

Research output: Contribution to journalArticle

Ishiguro, Hiroyuki ; Yoshida, Hiroaki ; Major, Amy S. ; Zhu, Tianli ; Babaev, Vladimir R. ; Linton, MacRae F. ; Fazio, Sergio. / Retrovirus-mediated Expression of Apolipoprotein A-I in the Macrophage Protects against Atherosclerosis in Vivo. In: Journal of Biological Chemistry. 2001 ; Vol. 276, No. 39. pp. 36742-36748.
@article{04fd9376197040d6b4e6e2a97e6dd08e,
title = "Retrovirus-mediated Expression of Apolipoprotein A-I in the Macrophage Protects against Atherosclerosis in Vivo",
abstract = "We have previously reported that the lack of apolipoprotein (apo) E expression by macrophages promotes foam cell formation in vivo. Because transgenic mice overexpressing human apoA-I from the liver (h-apoA-I TgN) are protected from the atherogenesis induced by apoE deficiency, we hypothesized that the presence of apoA-I in the vessel wall could reduce the negative effect of apoE deficiency on lesion growth. To address this issue, we used both retroviral transduction and transgenic approaches to produce in vivo systems where apoA-I is expressed from macrophages. In the retroviral transduction study, apoA-I-deficient (apoA-I-/-) mice reconstituted with apoE-deficient (apoE-/-) bone marrow cells that were infected with a retroviral vector expressing human apoA-I (MFG-HAI) had 95{\%} lower atherosclerotic lesion area than that of recipients of apoE-/- bone marrow cells infected with the parental virus (MFG). To determine whether the protective effect of locally produced apoA-I was due to the lack of systemic apoA-I, we conducted a different experiment using h-apoA-I TgN mice as recipients of apoE-/- bone marrow with or without human apoA-I (driven by a macrophage-specific transgene defined as mφ-AI). Aortic lesion area in apoE-/-/mφ-AI → h-apoA-I TgN mice was decreased by 85{\%} compared with apoE-/- → h-apoA-I TgN mice. These data demonstrate that expression of apoA-I from macrophages protects against atherogenesis without affecting plasma apoA-I and high density lipoprotein cholesterol levels.",
author = "Hiroyuki Ishiguro and Hiroaki Yoshida and Major, {Amy S.} and Tianli Zhu and Babaev, {Vladimir R.} and Linton, {MacRae F.} and Sergio Fazio",
year = "2001",
month = "9",
day = "28",
doi = "10.1074/jbc.M106027200",
language = "English (US)",
volume = "276",
pages = "36742--36748",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "39",

}

TY - JOUR

T1 - Retrovirus-mediated Expression of Apolipoprotein A-I in the Macrophage Protects against Atherosclerosis in Vivo

AU - Ishiguro, Hiroyuki

AU - Yoshida, Hiroaki

AU - Major, Amy S.

AU - Zhu, Tianli

AU - Babaev, Vladimir R.

AU - Linton, MacRae F.

AU - Fazio, Sergio

PY - 2001/9/28

Y1 - 2001/9/28

N2 - We have previously reported that the lack of apolipoprotein (apo) E expression by macrophages promotes foam cell formation in vivo. Because transgenic mice overexpressing human apoA-I from the liver (h-apoA-I TgN) are protected from the atherogenesis induced by apoE deficiency, we hypothesized that the presence of apoA-I in the vessel wall could reduce the negative effect of apoE deficiency on lesion growth. To address this issue, we used both retroviral transduction and transgenic approaches to produce in vivo systems where apoA-I is expressed from macrophages. In the retroviral transduction study, apoA-I-deficient (apoA-I-/-) mice reconstituted with apoE-deficient (apoE-/-) bone marrow cells that were infected with a retroviral vector expressing human apoA-I (MFG-HAI) had 95% lower atherosclerotic lesion area than that of recipients of apoE-/- bone marrow cells infected with the parental virus (MFG). To determine whether the protective effect of locally produced apoA-I was due to the lack of systemic apoA-I, we conducted a different experiment using h-apoA-I TgN mice as recipients of apoE-/- bone marrow with or without human apoA-I (driven by a macrophage-specific transgene defined as mφ-AI). Aortic lesion area in apoE-/-/mφ-AI → h-apoA-I TgN mice was decreased by 85% compared with apoE-/- → h-apoA-I TgN mice. These data demonstrate that expression of apoA-I from macrophages protects against atherogenesis without affecting plasma apoA-I and high density lipoprotein cholesterol levels.

AB - We have previously reported that the lack of apolipoprotein (apo) E expression by macrophages promotes foam cell formation in vivo. Because transgenic mice overexpressing human apoA-I from the liver (h-apoA-I TgN) are protected from the atherogenesis induced by apoE deficiency, we hypothesized that the presence of apoA-I in the vessel wall could reduce the negative effect of apoE deficiency on lesion growth. To address this issue, we used both retroviral transduction and transgenic approaches to produce in vivo systems where apoA-I is expressed from macrophages. In the retroviral transduction study, apoA-I-deficient (apoA-I-/-) mice reconstituted with apoE-deficient (apoE-/-) bone marrow cells that were infected with a retroviral vector expressing human apoA-I (MFG-HAI) had 95% lower atherosclerotic lesion area than that of recipients of apoE-/- bone marrow cells infected with the parental virus (MFG). To determine whether the protective effect of locally produced apoA-I was due to the lack of systemic apoA-I, we conducted a different experiment using h-apoA-I TgN mice as recipients of apoE-/- bone marrow with or without human apoA-I (driven by a macrophage-specific transgene defined as mφ-AI). Aortic lesion area in apoE-/-/mφ-AI → h-apoA-I TgN mice was decreased by 85% compared with apoE-/- → h-apoA-I TgN mice. These data demonstrate that expression of apoA-I from macrophages protects against atherogenesis without affecting plasma apoA-I and high density lipoprotein cholesterol levels.

UR - http://www.scopus.com/inward/record.url?scp=0035965336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035965336&partnerID=8YFLogxK

U2 - 10.1074/jbc.M106027200

DO - 10.1074/jbc.M106027200

M3 - Article

C2 - 11477092

AN - SCOPUS:0035965336

VL - 276

SP - 36742

EP - 36748

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 39

ER -